Cart
sales@molnova.com
Canocapavir
CAS No. 2137847-19-7
Canocapavir( —— )
Catalog No. M35755 CAS No. 2137847-19-7
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 454 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCanocapavir
-
NoteResearch use only, not for human use.
-
Brief DescriptionCanocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
-
DescriptionCanocapavir (ZM-H1505R) has orally antiviral activity. Canocapavir is a HBV capsid inhibitor that can be used in the research of Chronic hepatitis B. .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2137847-19-7
-
Formula Weight562.39
-
Molecular FormulaC27H21BrFN5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 300 mg/mL (533.44 mM; Ultrasonic (<60°C)
-
SMILESC(CC=1C=C2C(=CC1)NC(=O)N2)N3[C@@H](C=4C(=NN(C4)C5=CC=C(Br)C=C5)C6=CC=C(F)C=C6)OCC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true
molnova catalog
related products
-
AT-130
AT-130 is a potent inhibitor of HBV capsid assembly, inhibits wild-type HBV replication with IC50 of 2.4 uM.
-
Alisol F
Alisol F is a natural product from Alisma plantago-aquatica Linn and has many activities.Alisol F shows anti-inflammatory activities and liver protection through the inhibition of MAPK, STAT3, and NF-κB activation in vitro and in vivo, it suppresses iNOS induction.
-
Antiviral agent
Antiviral agent is thiazolidin-4-one with anti-hepatitis B activity
